{"url":"https://lda.senate.gov/api/v1/filings/09ede02e-e4cd-4eb4-b37a-c51c172abe59/","filing_uuid":"09ede02e-e4cd-4eb4-b37a-c51c172abe59","filing_type":"Q4","filing_type_display":"4th Quarter - Report","filing_year":2025,"filing_period":"fourth_quarter","filing_period_display":"4th Quarter (Oct 1 - Dec 31)","filing_document_url":"https://lda.senate.gov/filings/public/filing/09ede02e-e4cd-4eb4-b37a-c51c172abe59/print/","filing_document_content_type":"text/html","income":"60000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Chris Jones","dt_posted":"2026-01-17T14:15:08-05:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"1050 Connecticut Ave NW Suite 1100","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20036","registrant":{"id":5131,"url":"https://lda.senate.gov/api/v1/registrants/5131/","house_registrant_id":30019,"name":"BAKER & HOSTETLER LLP","description":"Law firm","address_1":"1050 Connecticut Ave NW Suite 1100","address_2":null,"address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20036","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"CHRIS JONES","contact_telephone":"+1 202-861-1500","dt_updated":"2026-01-30T17:14:19.044047-05:00"},"client":{"id":56735,"url":"https://lda.senate.gov/api/v1/clients/56735/","client_id":56735,"name":"FERRING PHARMACEUTICALS, INC.","general_description":"Biopharmaceutical company","client_government_entity":null,"client_self_select":false,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2023-07-01"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Regulatory and reimbursement policy issues related to federal healthcare programs associated with gene therapy, IVF therapy and oncology treatments.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":64122,"prefix":null,"prefix_display":null,"first_name":"CHRIS","nickname":null,"middle_name":null,"last_name":"JONES","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":64123,"prefix":null,"prefix_display":null,"first_name":"ADAM","nickname":null,"middle_name":null,"last_name":"HIGGINS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":59478,"prefix":null,"prefix_display":null,"first_name":"TYLER","nickname":null,"middle_name":null,"last_name":"THOMPSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146764,"prefix":null,"prefix_display":null,"first_name":"PETER","nickname":null,"middle_name":null,"last_name":"ROSKAM","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}